Recommendations from SCAI experts support the safety of PCI without on-site surgery

Published Date: 02 Mar 2023

Recommendations from SCAI experts support the safety of PCI without on-site surgery

Read Full News

Latest News

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Episode 3: Cracking the Code: Insulin Resistance in HS

What if your HS patient's normal labs are hiding a metabolic storm? Drs Okoye and Bordone explore overlooked clues, HOMA-IR, and real-world GLP-1 outcomes.

Medicaid Status May Worsen Complications After Heart Transplantation

Medicaid Status May Worsen Complications After Heart Transplantation

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

Aesthetician Charged With Injecting Customers With Counterfeit Botox

Some clients faced life-threatening injuries after receiving injections, said federal authorities

What to Know About President Trump's Order Targeting Transgender Rights

A closer look at the executive order

Todays Updates

Episode 156: Building Better Mood and Behavior Care for Parkinson Disease Marco Meglio, Sneha Mantri, MD, MS

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Sneha Mantri, MD, MS. [LISTEN TIME: 24 minutes]

FDA Approves Inebilizumab for AChR- and MuSK-Positive Generalized Myasthenia Gravis Isabella Ciccone, MPH

Inebilizumab is the first CD19-targeted B-cell therapy approved for antiAChR- or antiMuSK antibody–positive generalized myasthenia gravis, providing symptom control with twice-yearly dosing.

Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome

Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome

Todays Updates

Episode 156: Building Better Mood and Behavior Care for Parkinson Disease Marco Meglio, Sneha Mantri, MD, MS

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Sneha Mantri, MD, MS. [LISTEN TIME: 24 minutes]

FDA Approves Inebilizumab for AChR- and MuSK-Positive Generalized Myasthenia Gravis Isabella Ciccone, MPH

Inebilizumab is the first CD19-targeted B-cell therapy approved for antiAChR- or antiMuSK antibody–positive generalized myasthenia gravis, providing symptom control with twice-yearly dosing.

Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome

Weight-Adjusted Waist Index Can Predict CVD Risk in Cardiovascular Kidney Metabolic Syndrome

Latest News

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

What if your HS patient's normal labs are hiding a metabolic storm? Drs Okoye and Bordone explore overlooked clues, HOMA-IR, and real-world GLP-1 outcomes.

Medicaid Status May Worsen Complications After Heart Transplantation

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

Some clients faced life-threatening injuries after receiving injections, said federal authorities

A closer look at the executive order

News All Time

New Guideline Revises Cautions Around Dental Work in Joint Replacement Patients

Surgeons' groups acknowledge that prophylactic antibiotics may not cut infection risk

How 'General Hospital' Missed a Chance to Promote Living Organ Donation

A recent storyline offered a negative spin

Half-Truths, Big Risks: The Dangers of an Incomplete Medical History

Creating an environment that fosters open communication is essential

Anthem Blue Cross Blue Shield Reverses Decision to Put a Time Limit on Anesthesia

Change comes after widespread outcry

Inside the OR: Cervical Artificial Disc Replacement

Watch orthopedic spinal surgeon Antonio Webb, MD, perform this complex procedure

Trump's FDA Pick Is MedPage Today's Former Top Editor

Marty Makary has made a name for himself challenging the medical establishment

How Impactful is EMPACT-MI on Heart Failure: EMPACT-MI Trial

The trial evaluated the efficacy of empagliflozin to reduce cardiovascular risk in patients after acute myocardial infarction.

Nationwide IV Fluid Shortage Could Change How Hospitals Manage Patient Hydration

Crisis expected to last a long time, according to one expert

One-day Decompression at Allegheny Health Network

One-day Decompression at Allegheny Health Network

Alarming Surge in Alcohol-Related Liver Transplants in Younger Adults

Targeted preventive strategies needed, especially for younger women, researchers say

Health Worker Gets 2 Years for Accessing Ruth Bader Ginsburg's Medical Records

Transplant coordinator was convicted earlier this year

The Robot Will See You Now

Robotics may not be the answer for primary care right now, but "smart systems" sure could help

Resistance Training Falls Short in Severe Hip Arthritis

Trial finds conservative approach inferior to joint replacement

People Opting Out of Organ Donation After Donor Mistakenly Declared Dead

The alleged incident even affected donations in France

I'm a Black Trauma Surgeon. Ending Gun Violence Demands Fighting for Racial Justice.

An excerpt from Williams' book, The Bodies Keep Coming

UVA Health Surgeons Sound Alarm on Upcoding

Leaked meeting audio latest development in ongoing strife at health system, medical school

Recommended News For You

Higher Risk of Kidney Cancer Recurrence After Ablative Therapy

A new FDA boxed warning; suicides rocking college campuses; more people getting flu shots than COVID vaccines.

Gene therapy and chemotherapy may be combined in novel ways to treat bone cancer.

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

TULSA Is Effective in Long-Term Prostate Cancer Control.

Un nou sistem de endoscopică imaging are capacitatea de a detecta mai mulți fluorescent tracers.

Novel Agent for Chronic GVHD Wins FDA Approval

Recommended Articles For You

Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results 

The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025 

Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options  

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Specific suicidal patterns mark the highest risk.

2.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

3.

A paper strip test might enable the early detection of cancer.

4.

unhealthy sleeping habits and the risk of esophageal adenocarcinoma.

5.

Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.

1.

Precision Oncology: How Personalized Medicine is Transforming Cancer Treatment

2.

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

3.

Unlocking Life Expectancy After Subdural Hematoma: A New Hope

4.

Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers

5.

Mitoxantrone–Napabucasin Co-Nanoformulation Activates cGAS-STING in HCC Therapy

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

2.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

3.

Efficient Management of First line ALK-rearranged NSCLC - Part V

4.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot